Johnson & Johnson (JNJ): Price and Financial Metrics

Johnson & Johnson (JNJ): $158.46

1.49 (+0.95%)

POWR Rating

Component Grades








Add JNJ to Watchlist
Sign Up

Industry: Medical - Pharmaceuticals




#5 of 167

in industry

JNJ Price/Volume Stats

Current price $158.46 52-week high $183.35
Prev. close $156.97 52-week low $150.11
Day low $156.97 Volume 2,246,419
Day high $158.64 Avg. volume 7,609,456
50-day MA $160.01 Dividend yield 3.08%
200-day MA $165.43 Market Cap 411.80B

JNJ Stock Price Chart Interactive Chart >


  • Stability is the dimension where JNJ ranks best; there it ranks ahead of 96.39% of US stocks.
  • JNJ's strongest trending metric is Growth; it's been moving up over the last 179 days.
  • JNJ's current lowest rank is in the Momentum metric (where it is better than 17% of US stocks).

JNJ Stock Summary

  • JNJ has a higher market value than 99.74% of US stocks; more precisely, its current market capitalization is $407,117,680,190.
  • JNJ's went public 37.42 years ago, making it older than 93.61% of listed US stocks we're tracking.
  • In terms of volatility of its share price, JNJ is more volatile than merely 2.4% of stocks we're observing.
  • If you're looking for stocks that are quantitatively similar to JOHNSON & JOHNSON, a group of peers worth examining would be NVO, LLY, XOM, WMT, and UNH.
  • Visit JNJ's SEC page to see the company's official filings. To visit the company's web site, go to

JNJ Valuation Summary

  • JNJ's price/earnings ratio is 32; this is 32.78% higher than that of the median Healthcare stock.
  • JNJ's EV/EBIT ratio has moved up 11.5 over the prior 243 months.

Below are key valuation metrics over time for JNJ.

Stock Date P/S P/B P/E EV/EBIT
JNJ 2023-05-23 4.2 5.8 32.0 27.8
JNJ 2023-05-22 4.2 5.8 32.0 27.8
JNJ 2023-05-19 4.3 5.8 32.5 28.1
JNJ 2023-05-18 4.3 5.8 32.4 28.1
JNJ 2023-05-17 4.3 5.8 32.5 28.1
JNJ 2023-05-16 4.3 5.8 32.5 28.2

JNJ Growth Metrics

    The 2 year net income to common stockholders growth rate now stands at 15.52%.
  • Its year over year net income to common stockholders growth rate is now at 31.19%.
  • Its 2 year cash and equivalents growth rate is now at -32.63%.
Over the past 70 months, JNJ's revenue has gone up $22,769,000,000.

The table below shows JNJ's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-12-31 94,943 21,194 17,941
2022-09-30 96,041 21,576 19,157
2022-06-30 95,588 23,582 18,366
2022-03-31 94,880 23,315 19,830
2021-12-31 93,775 23,410 20,878
2021-09-30 91,446 26,021 17,880

JNJ's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • JNJ has a Quality Grade of B, ranking ahead of 92.45% of graded US stocks.
  • JNJ's asset turnover comes in at 0.52 -- ranking 78th of 682 Pharmaceutical Products stocks.
  • CBIO, CLSD, and ABBV are the stocks whose asset turnover ratios are most correlated with JNJ.

The table below shows JNJ's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-10-03 0.520 0.675 0.295
2021-07-04 0.514 0.670 0.302
2021-04-04 0.498 0.662 0.273
2021-01-03 0.501 0.656 0.272
2020-09-27 0.504 0.657 0.332
2020-06-28 0.514 0.657 0.307

JNJ Price Target

For more insight on analysts targets of JNJ, see our JNJ price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $187.95 Average Broker Recommendation 1.53 (Moderate Buy)

Johnson & Johnson (JNJ) Company Bio

Founded in 1886, Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture, and sale of products in the healthcare field within its Consumer, Pharmaceutical and Medical Devices segments. The Consumer segment consists of skin and self-care product brand names such as Aveeno, Neutrogena, Rogaine, Tylenol, Motrin, Listerine, and Band-Aid. Johnson’s Pharmaceutical segment contains biopharma products that address immune, cardiovascular, metabolic, and infectious disease medical conditions. The Medical Device segment develops products centered around orthopedic, surgical, intervention, and vision solutions. The company has over 130,000 employees worldwide and is headquartered in New Brunswick, New Jersey. The company’s current Chief Executive Officer is Alex Gorsky.

JNJ Latest News Stream

Event/Time News Detail
Loading, please wait...

JNJ Latest Social Stream

Loading social stream, please wait...

View Full JNJ Social Stream

Latest JNJ News From Around the Web

Below are the latest news stories about JOHNSON & JOHNSON that investors may wish to consider to help them evaluate JNJ as an investment opportunity.

The Little-Known Secret to Beating the S&P 500

If you can't beat the S&P 500 by picking individual stocks, owning an S&P 500 index fund and at least earning market returns is a smart move. Not just any dividend-paying stocks, mind you, but those that can grow their dividend payments consistently. Hartford Funds and Ned Davis Research have been tracking the average annual total returns of companies in the S&P 500 by dividend policy.

Yahoo | June 3, 2023

With 65% ownership, Johnson & Johnson (NYSE:JNJ) boasts of strong institutional backing

Key Insights Significantly high institutional ownership implies Johnson & Johnson's stock price is sensitive to their...

Yahoo | June 3, 2023

Two Dow Stocks to Buy in June and Hold for the Next Decade

These two stocks look like the best options among the Dow Jones Industrial Average's 30 components right now.

Yahoo | June 3, 2023

3 Retirement Stocks to Buy to Sleep Like a Baby

Watch out for these safe retirement stocks if you are planning to build a retirement portfolio and sleep like a baby.

Vandita Jadeja on InvestorPlace | June 2, 2023

3 Stocks That High-Yield ETFs Are Betting On

Growth stocks fill headlines, but investors are in search for lower-risk yields.

Tyrik Torres on InvestorPlace | June 2, 2023

Read More 'JNJ' Stories Here

JNJ Price Returns

1-mo -1.86%
3-mo 3.61%
6-mo -9.24%
1-year -7.65%
3-year 16.43%
5-year 47.42%
YTD -8.97%
2022 5.97%
2021 11.44%
2020 10.82%
2019 16.22%
2018 -5.13%

JNJ Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full JNJ Dividend History

Continue Researching JNJ

Want to see what other sources are saying about Johnson & Johnson's financials and stock price? Try the links below:

Johnson & Johnson (JNJ) Stock Price | Nasdaq
Johnson & Johnson (JNJ) Stock Quote, History and News - Yahoo Finance
Johnson & Johnson (JNJ) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!